Solid Biosciences (SLDB) Total Non-Current Liabilities: 2018-2024
Historic Total Non-Current Liabilities for Solid Biosciences (SLDB) over the last 1 years, with Sep 2024 value amounting to $21.9 million.
- Solid Biosciences' Total Non-Current Liabilities was N/A to $21.9 million in Q3 2024 from the same period last year, while for Sep 2024 it was $21.9 million, marking a year-over-year change of. This contributed to the annual value of $23.9 million for FY2023, which is 50.63% down from last year.
- Solid Biosciences' Total Non-Current Liabilities amounted to $21.9 million in Q3 2024, which was down 4.76% from $23.0 million recorded in Q2 2024.
- In the past 5 years, Solid Biosciences' Total Non-Current Liabilities registered a high of $48.5 million during Q4 2022, and its lowest value of $21.9 million during Q3 2024.
- Moreover, its 3-year median value for Total Non-Current Liabilities was $23.5 million (2023), whereas its average is $29.4 million.
- Data for Solid Biosciences' Total Non-Current Liabilities shows a maximum YoY plummeted of 50.63% (in 2023) over the last 5 years.
- Over the past 4 years, Solid Biosciences' Total Non-Current Liabilities (Quarterly) stood at $37.8 million in 2020, then reached $48.5 million in 2022, then slumped by 50.63% to $23.9 million in 2023, then reached $21.9 million in 2024.
- Its Total Non-Current Liabilities stands at $21.9 million for Q3 2024, versus $23.0 million for Q2 2024 and $23.9 million for Q4 2023.